$UPB

$2.79 +$0.04 (1.45%) Close

$UPB Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$UPB Management Team

Ms. Stacy Price

Chief Technology Officer

Age -

Compensation -

Sex Female

Mr. Ronald Renaud

Independent Chairman of the Board

Age 56

Compensation $816.3K USD

Sex Male

Dr. E. Rand Sutherland

Chief Executive Officer

Director

Age 55

Compensation $9.109M USD

Sex Male

Mr. Michael Gray

Chief Financial and Operating Officer

Age 54

Compensation $2.939M USD

Sex Male

Ms. Allison Ambrose

Senior Vice President

General Counsel

Age -

Compensation $1.534M USD

Sex Female

Dr. Aaron Deykin

Chief Medical Officer

Head - Research and Development

Age 59

Compensation $823.2K USD

Sex Male

Dr. Adam Houghton

Chief Business Officer

Age 54

Compensation -

Sex Male

Name / Title	Age	Compensation	Sex
Ms. Stacy Price Chief Technology Officer	-	-	Female
Mr. Ronald Renaud Independent Chairman of the Board	56	$816.3K USD	Male
Dr. E. Rand Sutherland Chief Executive Officer Director	55	$9.109M USD	Male
Mr. Michael Gray Chief Financial and Operating Officer	54	$2.939M USD	Male
Ms. Allison Ambrose Senior Vice President General Counsel	-	$1.534M USD	Female
Dr. Aaron Deykin Chief Medical Officer Head - Research and Development	59	$823.2K USD	Male
Dr. Adam Houghton Chief Business Officer	54	-	Male

Board of Directors

From the proxy statement filed Apr 16, 2026

Directors

serving now

Independent

6 of 7

stated in the proxy

Average tenure

3.6 years

from year joined

CEO also chairs the board

Ronald C. Renaud, Jr., M.B.A.

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
H. Edward Fleming, Jr., M.D.	63	2023 3 years	Independent	audit committee nominating and corporate governance committee	CRISPR Therapeutics AG, Sionna Therapeutics, Inc.	$201,510
Liam Ratcliffe, M.B.Ch.B., Ph.D., M.B.A.	62	2021 5 years	Independent	None stated	Disc Medicine, Inc.	$202,510
E. Rand Sutherland, M.D. CEO	56	2024 2 years	Not independent	None stated	Krystal Biotech, Inc.	Paid as CEO
Ronald C. Renaud, Jr., M.B.A. Board chair	57	2021 5 years	Independent	None stated	Kailera Therapeutics, Inc.	$231,010
Daniella Beckman	47	2024 2 years	Independent	None stated	Vor Biopharma Inc.	Not stated
Erez Chimovits, M.B.A., M.Sc.	62	2021 5 years	Independent	None stated	None stated	$196,810
Marcella Kuhlman Ruddy, M.D., M.S.	63	2023 3 years	Independent	None stated	Sionna Therapeutics, Inc.	$199,010

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 16, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Comments

Company Executives

$UPB Management Team

Ms. Stacy Price

Mr. Ronald Renaud

Dr. E. Rand Sutherland

Mr. Michael Gray

Ms. Allison Ambrose

Dr. Aaron Deykin

Dr. Adam Houghton

Board of Directors

Related-party transactions

No related-party transactions disclosed